Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-12 12:52 pm Purchase | 13G | Denali Therapeutics Inc. DNLI | Capital Research Global Investors | 7,909,114 5.500% | 7,909,114 (New Position) | View |
| 2024-11-12 09:55 am Purchase | 13G | Denali Therapeutics Inc. DNLI | FMR LLC | 10,141,901 7.084% | 2,949,956 (+41.02%) | View |
| 2024-11-08 5:31 pm Unchanged | 13G | Denali Therapeutics Inc. DNLI | BlackRock Inc. | 13,787,873 9.600% | 0 (Unchanged) | View |
| 2024-11-08 10:52 am Purchase | 13G | Denali Therapeutics Inc. DNLI | WELLINGTON MANAGEMENT GROUP LLP | 10,727,450 7.490% | 3,452,733 (+47.46%) | View |
| 2024-11-07 4:48 pm Sale | 13G | Denali Therapeutics Inc. DNLI | BIOGEN INC. BIIB | 7,155,243 4.970% | -5,596,122 (-43.89%) | View |
| 2024-10-21 4:11 pm Purchase | 13G | Denali Therapeutics Inc. DNLI | BlackRock Inc. | 13,787,873 9.600% | 13,787,873 (New Position) | View |
| 2024-08-16 1:18 pm Purchase | 13G | Denali Therapeutics Inc. DNLI | FMR LLC | 7,191,945 5.023% | 1,337,910 (+22.85%) | View |
| 2024-02-13 5:02 pm Purchase | 13G | Denali Therapeutics Inc. DNLI | VANGUARD GROUP INC | 10,834,483 7.840% | 887,385 (+8.92%) | View |
| 2024-02-13 4:27 pm Sale | 13G | Denali Therapeutics Inc. DNLI | BRATTON DOUGLAS K | 5,750,882 4.200% | -1,250,000 (-17.85%) | View |
| 2024-02-12 7:07 pm Sale | 13G | Denali Therapeutics Inc. DNLI | BIOGEN INC. BIIB | 12,751,365 9.230% | -558,878 (-4.20%) | View |
| 2024-02-08 10:11 am Purchase | 13G | Denali Therapeutics Inc. DNLI | WELLINGTON MANAGEMENT GROUP LLP | 7,274,717 5.260% | 7,274,717 (New Position) | View |
| 2024-01-30 06:59 am Sale | 13G | Denali Therapeutics Inc. DNLI | BAILLIE GIFFORD & CO | 14,260,724 10.320% | -858,750 (-5.68%) | View |
| 2024-01-30 06:40 am Unchanged | 13G | Denali Therapeutics Inc. DNLI | Temasek Holdings (Private) Ltd | 6,895,992 4.900% | 0 (Unchanged) | View |
| 2024-01-25 4:59 pm Purchase | 13G | Denali Therapeutics Inc. DNLI | BlackRock Inc. BLK | 11,542,861 8.400% | 2,221,432 (+23.83%) | View |
| 2023-03-30 06:14 am Purchase | 13G | Denali Therapeutics Inc. DNLI | Temasek Holdings (Private) Ltd | 6,895,992 5.000% | 6,895,992 (New Position) | View |
| 2023-02-13 4:14 pm Sale | 13G | Denali Therapeutics Inc. DNLI | BRATTON DOUGLAS K | 7,000,882 5.200% | -844,307 (-10.76%) | View |
| 2023-02-09 11:16 am Purchase | 13G | Denali Therapeutics Inc. DNLI | VANGUARD GROUP INC | 9,947,098 7.320% | 1,785,568 (+21.88%) | View |
| 2023-02-09 08:14 am Sale | 13G | Denali Therapeutics Inc. DNLI | FMR LLC | 5,854,035 4.310% | -737,998 (-11.20%) | View |
| 2023-01-31 5:52 pm Purchase | 13G | Denali Therapeutics Inc. DNLI | BlackRock Inc. BLK | 9,321,429 6.900% | 1,210,607 (+14.93%) | View |
| 2023-01-20 10:05 am Purchase | 13G | Denali Therapeutics Inc. DNLI | BAILLIE GIFFORD & CO | 15,119,474 11.130% | 63,093 (+0.42%) | View |